This, and many other mechanisms utilized by heparanase to promote tumorigenesis (3, 5–9), have turned this enzyme into a promising drug target and heparanase inhibitors are currently being evaluated in clinical trials as anti-cancer (10, 11) and anti-viral (12) drugs. Here, HPSE is linked to cancer.